Rigaud Olivier 4

What Happened

• Olivier Rigaud, a director of Balchem Corp (BCPC), received a grant of 870 restricted shares on February 11, 2026. The Form 4 reports the acquisition as an award (transaction code A) at $0.00 per share (total recorded value $0).
• This was an equity compensation grant — an acquisition of restricted stock issued by the company, not an open-market purchase.

Key Details

• Transaction date: 2026-02-11; Form 4 filed: 2026-02-13 (appears timely).
• Shares acquired: 870 restricted shares; price reported: $0.00 per share; total reported value: $0.
• Shares owned after the transaction: Not specified in the provided filing.
• Footnote: The restricted stock vests one year after the grant date and remains subject to transfer restrictions under the Restricted Stock Grant Agreement.
• Transaction type: Award/Grant (Form 4 code A) — not a sale or open-market purchase.

Context

• Restricted stock grants are a common form of director compensation and typically vest over time; they reflect compensation rather than an immediate market view by the insider.
• Because the award vests in one year and is transfer-restricted, the shares are not immediately liquid and should not be interpreted as an immediate buy signal.